posted on 2020-08-25, 18:00authored byAda AdminAda Admin, Jianchun Chen, Xiaoyong Wang, Qian He, Nada Bulus, Agnes B. Fogo, Ming-Zhi Zhang, Raymond C. Harris
Increasing studies have suggested that the
renal proximal tubule is a site of injury in diabetic nephropathy (DN), and
progressive renal tubulointerstitial
fibrosis is an important mediator of progressive kidney dysfunction in
DN.
In this study, we observed increased expression and activation of YAP (Yes-associated protein) in renal
proximal tubule epithelial cells (RPTC) in diabetic patient and mouse
kidneys. Inducible deletion of Yap specifically in RPTC or
administration of the YAP inhibitor verteporfin significantly attenuated diabetic tubulointerstitial fibrosis. EGFR-dependent activation of RhoA/Rock and PI3K-Akt signals and their
reciprocal interaction were upstream of proximal tubule YAP activation
in diabetic kidneys. Production and release of CTGF in culture medium were
significantly augmented in HEK293 transfected with a constitutively active YAP
mutant, and the conditioned medium collected from these cells activated and
transduced fibroblasts into myofibroblasts. This study demonstrates that proximal
tubule YAP dependent paracrine mechanisms play an important role in diabetic
interstitial fibrogenesis; therefore, targeting Hippo signaling may be a
therapeutic strategy to prevent the development and progression of diabetic
interstitial fibrogenesis.
Funding
This work was supported by funds from American Diabetes Association grant #1-18-IBS-267 (to J.C); National Institutes of Health Grant DK51265, DK62794 and DK79341 (to R.C.H and M-Z.Z.), Department of Veterans Affairs grant 00507969 (to R.C.H), and support by the Vanderbilt O’Brien Kidney Center (DK114809).